tiprankstipranks
Conduit Pharmaceuticals (CDT)
NASDAQ:CDT
US Market

Conduit Pharmaceuticals (CDT) Stock Price & Analysis

26 Followers

CDT Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.95 - $25.00
Previous Close$2.97
Volume15.02K
Average Volume (3M)34.04K
Market Cap
$219.27M
Enterprise Value$210.81M
Total Cash (Recent Filing)$8.64M
Total Debt (Recent Filing)$177.00K
Price to Earnings (P/E)134.4
Beta0.28
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.02
Shares Outstanding73,829,536
10 Day Avg. Volume17,558
30 Day Avg. Volume34,039
Standard Deviation0.39
R-Squared0.12
Alpha0.00090
Financial Highlights & Ratios
Price to Book (P/B)-207.18
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-33.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-733.66
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Ownership Overview

5.56%0.59%0.28%93.58%
0.28% Other Institutional Investors
93.58% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

CDT FAQ

What was Conduit Pharmaceuticals’s price range in the past 12 months?
Conduit Pharmaceuticals lowest stock price was $0.95 and its highest was $25.00 in the past 12 months.
    What is Conduit Pharmaceuticals’s market cap?
    Currently, no data Available
    When is Conduit Pharmaceuticals’s upcoming earnings report date?
    The company’s upcoming earnings report date is not yet available.
    How were Conduit Pharmaceuticals’s earnings last quarter?
    Currently, no data Available
    Is Conduit Pharmaceuticals overvalued?
    According to Wall Street analysts Conduit Pharmaceuticals’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
      Does Conduit Pharmaceuticals pay dividends?
      Conduit Pharmaceuticals does not currently pay dividends.
      What is Conduit Pharmaceuticals’s EPS estimate?
      Conduit Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
      How many shares outstanding does Conduit Pharmaceuticals have?
      Conduit Pharmaceuticals has 73,829,540 shares outstanding.
        What happened to Conduit Pharmaceuticals’s price movement after its last earnings report?
        Currently, no data Available
        Which hedge fund is a major shareholder of Conduit Pharmaceuticals?
        Among the largest hedge funds holding Conduit Pharmaceuticals’s share is Saba Capital Management. It holds Conduit Pharmaceuticals’s shares valued at N/A.
          ---

          Company Description

          Conduit Pharmaceuticals

          Murphy Canyon Acquisition Corp is a blank check company.
          ---
          Similar Stocks
          Company
          Price & Change
          Follow
          Bristol-Myers Squibb
          GlaxoSmithKline
          Novartis
          Popular Stocks
          ---
          What's Included in PREMIUM?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis